Literature DB >> 17413445

Brain-derived neurotrophic factor gene polymorphisms and schizophrenia: a meta-analysis.

Elias Zintzaras1.   

Abstract

OBJECTIVES: To evaluate whether the G196A and C270T polymorphisms of the brain-derived neurotrophic factor gene are associated with increased risk of schizophrenia.
METHODS: A meta-analysis of nine genetic association studies was carried out. The meta-analysis included genotype data on 1404/1597 schizophrenics/controls for G196A and 877/989 schizophrenics/controls for C270T.
RESULTS: The overall analysis for investigating the association of the G196A allele G and the risk of developing schizophrenia relative to the allele A, showed significant evidence of heterogeneity (P=0.05, I(2)=58%) between the studies and nonsignificant association [random effects odds ratio 1.08 and 95% confidence interval (0.88-1.32)]. In Caucasians, there was a trend towards heterogeneity (P=0.19, I(2)=40%), then, the random and fixed effects odds ratios were 1.24 (0.96-1.60) and 1.27 (1.06-1.53), respectively. For the C270T polymorphism, overall, there was significant evidence of heterogeneity between studies (P=0.07, I(2)=55%) and the allele T was associated with a 63% increased risk of schizophrenia compared with C allele [random effects odds ratio 1.63 (1.01-2.65)]. The dominant model for allele T produced significant association [random effects odds ratio 1.68 (1.02-2.79)]. No source of bias was seen in the selected studies and the differential magnitude of effect in large versus small studies was not significant.
CONCLUSIONS: The meta-analysis results provided a weak evidence of association between C270T polymorphism and schizophrenia, and large heterogeneity between studies, whereas there was no evidence of association for G196A polymorphism. The above findings reinforce the need for large and more rigorous association studies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17413445     DOI: 10.1097/YPG.0b013e32801119da

Source DB:  PubMed          Journal:  Psychiatr Genet        ISSN: 0955-8829            Impact factor:   2.458


  20 in total

1.  Maternal gene polymorphisms involved in folate metabolism and risk of Down syndrome offspring: a meta-analysis.

Authors:  Elias Zintzaras
Journal:  J Hum Genet       Date:  2007-10-13       Impact factor: 3.172

2.  Trends in meta-analysis of genetic association studies.

Authors:  Elias Zintzaras; Joseph Lau
Journal:  J Hum Genet       Date:  2007-12-12       Impact factor: 3.172

Review 3.  Fibroblast growth factors in schizophrenia.

Authors:  Afke F Terwisscha van Scheltinga; Steven C Bakker; René S Kahn
Journal:  Schizophr Bull       Date:  2009-05-08       Impact factor: 9.306

4.  Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy: a meta-analysis.

Authors:  Elias Zintzaras; Katrin Uhlig; George N Koukoulis; Afroditi A Papathanasiou; Ioannis Stefanidis
Journal:  J Hum Genet       Date:  2007-09-06       Impact factor: 3.172

Review 5.  The BDNF gene Val66Met polymorphism as a modifier of psychiatric disorder susceptibility: progress and controversy.

Authors:  M Notaras; R Hill; M van den Buuse
Journal:  Mol Psychiatry       Date:  2015-03-31       Impact factor: 15.992

6.  Expression of GABA signaling molecules KCC2, NKCC1, and GAD1 in cortical development and schizophrenia.

Authors:  Thomas M Hyde; Barbara K Lipska; Towhid Ali; Shiny V Mathew; Amanda J Law; Ochuko E Metitiri; Richard E Straub; Tianzhang Ye; Carlo Colantuoni; Mary M Herman; Llewellyn B Bigelow; Daniel R Weinberger; Joel E Kleinman
Journal:  J Neurosci       Date:  2011-07-27       Impact factor: 6.167

7.  The role of MTHFR gene in multiple myeloma.

Authors:  Elias Zintzaras; Stavroula Giannouli; Paraskevi Rodopoulou; Michael Voulgarelis
Journal:  J Hum Genet       Date:  2008-03-19       Impact factor: 3.172

8.  Association of the brain-derived neurotrophic factor gene G196A rs6265 polymorphisms and the cognitive function and clinical symptoms of schizophrenia.

Authors:  Jinguo Zhai; Qing Yu; Min Chen; Yan Gao; Qiumei Zhang; Jun Li; Keqin Wang; Feng Ji; Zhonghua Su; Wu Li; Xuemei Li; Juyao Qiao
Journal:  Int J Clin Exp Pathol       Date:  2013-07-15

9.  A Review of Brain-derived Neurotrophic Factor as a Candidate Biomarker in Schizophrenia.

Authors:  Milawaty Nurjono; Jimmy Lee; Siow-Ann Chong
Journal:  Clin Psychopharmacol Neurosci       Date:  2012-08-31       Impact factor: 2.582

10.  ACSL6 is associated with the number of cigarettes smoked and its expression is altered by chronic nicotine exposure.

Authors:  Jingchun Chen; Darlene H Brunzell; Kia Jackson; Andrew van der Vaart; Jennie Z Ma; Thomas J Payne; Richard Sherva; Lindsay A Farrer; Pablo Gejman; Douglas F Levinson; Peter Holmans; Steven H Aggen; Imad Damaj; Po-Hsiu Kuo; Bradley T Webb; Raymond Anton; Henry R Kranzler; Joel Gelernter; Ming D Li; Kenneth S Kendler; Xiangning Chen
Journal:  PLoS One       Date:  2011-12-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.